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Background: Extraneural and extracranial metastases of glioblastoma (GB) are very rarely reported in the literature.
They occur in only 0.2% of all GB patients.
Case presentation: We present a 40 year old caucasian male with secondary GB and first diagnosis of an
astrocytoma world health organisation (WHO) grade II through stereotactic biopsy in 2006. He presented a new
hemiparesis and a progress of the known mass lesion in 2008. Subtotal tumor resection was performed and the
histological examination verified a GB. After combined radio- and chemotherapy the adjuvant temozolomide
therapy was not started because of non-compliance.
In 2011 a second local relapse was resected and 4 month later the patient presented a fast progressing tetraparesis.
Cervical CT and MRI scan showed a mass lesion infiltrating the fifth and sixth vertebra with infiltration of the spinal
canal and large paravertebral tumor masses. Emergency surgery was performed. By additional screening further
metastases were detected in the thoracal and lumbal spine and surprisingly also in the lung and pulmonary
lymphnodes. Palliative radio- and chemotherapy of the pulmonal lesions was completed, further antitumor therapy
was rejected. The patient died 10 months after diagnosis of the extraneural metastases.
Conclusion: Especially young “long-term-survivors” seem to have a higher risk of extraneural metastasis from a GB
and appropriate staging should be performed in these cases.
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Glioblastoma (GB) is known as a highly aggressive neuro-
epithelial tumor almost exclusively growing in the neural
tissue. Extraneural metastases were rarely reported in the
literature. The incidence of extraneural metastases is 0.2%
of all GB patients (Hsu E, 1998) [1]. In 2008 Piccirilli et al.
[2] reviewed the literature from 1928 to 2006 and reported
about 128 cases of extraneural metastases of GB.* Correspondence: Jan.Bostroem@ukb.uni-bonn.de
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reproduction in any medium, provided the orRemarkably, the average age of these patients at presen-
tation was 40, whereas otherwise the mean age of the
first diagnosis of cerebral GB is 54 years [3]. In
addition, the mean overall survival of patients with
extraneural metastasis was at least 17 months (Piccirilli
et al., 2008). From this, one can conclude that - due to
the younger age which is related with better overall sur-
vival in GB patients - those patients have the potential
developing extraneural metastases.
We present a case of a 40 year old patient with first
diagnosis of an Astrocytoma World Health Organization
(WHO) grade II in 2006, a secondary GB in 2008 and
multiple extraneural metastases in 2011. AlthoughLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.









Osseous Spine Lung (incl. Pleura) Liver Lymph nodes Abdominal
Piccirilli M et al. (review) Tumori/2008 128 41/82 26 32 51 20 42 14
Templeton A et al. Onkologie/2008 2 1/1 1 0 2 0 0 0
Rajagopalin V et al. (review) J Neurooncol/2005 15 unknown 3 12 0 0 0 0
Hsu E et al. (review) J Neurooncol/1998 1 unknown 1 0 0 0 0 0
Futoshi M et al. Clin Imag/1994 1 1/0 0 1 0 0 0 0
Beauchesne P et al. J Neurosurg/1993 1 0/1 0 1 0 0 0 0
Liwnicz H et al. Hum Pathol/1979 3 0/3 0 2 1 0 0 0
Terheggen HG et al. Eur J Pediatr/1977 1 0/1 1 0 0 0 0 0
Leifer D et al. J Neurosurg/1971 1 0/1 0 0 1 0 0 0
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reported, to our best knowledge this is the first report of
a case with so many metastases in different tissues (see
Table 1).
Case presentation
At age 35 this caucasian male initially presented with a
simple partial seizure on the left side in 2006. ThereFigure 1 MRI of the brain at four timepoints. Each row resembles one
enhanced T1 and axial T2 (or Flair,l). After the first MRI in 2006 (a,e,i), show
Astrocytoma WHO II° was diagnosed. In 2008, recurrent tumor (b,f,j) with s
malignisation to Glioblastoma WHO IV°, was proven by MRI. Again tumor r
2011 and surgery was performed. In 08/2011 (d,h,l) MRI of the brain showe
responsible for the deteriorating neurological status.were no other diseases reported in the medical history of
the patient. Karnofsky Performance Status (KPS) on ad-
mission was 90 and his antiepileptic drug therapy was
based on oxcarbazepine and clobazam. Magnetic reson-
ance imaging (MRI) showed a mass lesion (3 centimeter
(cm) × 2 cm) in the right central region (see Figure 1).
Stereotactic biopsy histologically verified an Astrocy-
toma WHO grade II. Postoperatively the patient sufferedexamination with coronal acquisition of Flair (or T2, d), coronal contrast
ing a non-enhancing tumor, the patient underwent surgery and
triking contrast enhancement (f), correlating with histologically proven
ecurrence with rim enhancing tumor (c, g, k), was documented in 04/
d that the local contrast enhancing tumor was under control and not
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dexamethason. Because of the histological result no ad-
juvant therapy was performed, only regular MRI controls
were planned.
In 2008 the patient presented an aggravated hemipar-
esis, a new hemihypaesthesia and a coordination failure
on the left side. The patient reported about an increase
of the seizure frequency with a simple partial seizure
every four days. Follow up MRI showed a progress of
the known mass lesion with new contrast medium en-
hancement (see Figure 1).Figure 2 Cervical MRI and CT. In the first and second row sagittal and pa
contrast enhancement (c) are shown. There is a vertebral tumor infiltration
canal (arrow). Larger tumor masses are found in the right lateral paravertebral
hypointens in T1 and is partially contrast enhancing (arrowhead) with central
the intervertebral foramina in an hour glass pattern (last row, a) like a schwa
CT). The infiltrated vertebrae are only slightly hyperdens compared to the noA debulking with subtotal tumor resection was
performed and the histological examination verified a sec-
ondary glioblastoma multiforme (GB). After the surgery
a combined radiation therapy (RT) (5 × 2 Gray (Gy)
per week, ad total dose of 60 Gy) and chemotherapy (75
mg/m2 temozolomide per day) was performed, but because
of non-compliance the planned adjuvant temozolomide
chemotherapy was not started.
Because of recurrent tumor growth and chronic local
wound infection a revision surgery was performed in
April 2011 (see Figure 1).rasagittal images of the cervical spine in T2 (a), T1 (b) and T1 with
of the fifth and sixth vertebra with a small invasion into the spinal
space (second row). The tumor is hyperintens in T2 (a, arrowheads),
non-enhancing parts (arrow in c). Remarkably the tumor grows through
nnoma even with enlargement of the osseous canal (arrow in b, axial
rmal vertebrae (arrowheads in c).
Figure 3 Intraoperative view 1. First step of decompression through laminectomie of C5. Arrows show the spinal cord. Arrowhead 1 shows
extraspinal tumormass infiltrating paravertebral muscles. Arrowhead 2 shows intraspinal/extradural tumormass.
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microbiologically propionibacterium was isolated and
treated with metronidazole and flucloxacillin. Clinically
the patient remains stable with a mild hemiparesis left
and a KPS of 70 at discharge.
In August 2011 the patient was admitted to the neuro-
surgical department again because of a fast progressing
tetraparesis and ischuria over a few days. The
tetraparesis was accentuated on the left side. KPS was 30
at this time. MRI of the brain showed that the localFigure 4 Intraoperative view 2. Segment C5 after bony decompression.
tumormass with GB typical necrosis and compression of the myelon.contrast enhancing tumor was under control and not re-
sponsible for the deteriorating neurological status. CT
and MRI scan of the cervical spine revealed a tumor in-
filtration of the fifth and sixth vertebra with an invasion
into the spinal canal and large paravertebral tumor
masses (see Figure 2).
Emergency surgery on the cervical spine with laminec-
tomy of cervical vertebra 5 and 6, pediculotomy of cer-
vical vertebra 6 and subtotal tumor resection was
performed (see Figures 3 and 4).Arrows point on spinal cord. Arrowheads show the intraspinal
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taken.
In suspicion of a pulmonary embolism after surgery a
CT-scan of the thorax was made and, surprisingly, ex-
tended right hilar and infracarinal tumor masses with in-
filtration of the right pulmonary artery were detected.
Additionally thromboembolic material was found in
branches of both pulmonary arteries (see Figure 5). The
mass lesions in the lung and the cervical spine were his-
tologically confirmed as metastases from the cerebral
glioblastoma (see Figure 6).
Because of the multiple mass lesions in different tis-
sues staging was completed with MRI of the whole spine
showing multifocal osseous metastases (see Figure 5).Figure 5 Staging with CT of the thorax and spinal MRI. Contrast enhan
b-d in 08/2011) hilar (white arrow in a and b) and infracarinal (black arr
pulmonary artery. Additionally thromboembolic material was found in bran
and lumbar (f) spine showed multifocal osseous metastases (arrows).Lumbar puncture was made with no pathological result.
The abdomen CT showed no pathological findings.
Postoperativly the tetraparesis regressed, lung function
was normal and KPS on discharge was 40.
A combined RT and chemotherapy was subsequently
performed in September 2011 with irradiation of the
metastatic mediastinal, infracarinal, pretracheal, retrocaval
and hilar lesions in a fractionation of 15 × 3 Gy up to
a total target volume dose of 45 Gy in a palliative
intention. RT was well tolerated without significant acute
radiation-induced toxicities. Additional chemotherapy
with temozolomide (150 mg/m2, 300 mg absolute per 5
days), was performed once, a repetition was again rejected
by the patient.ced CT of the thorax (a-d) revealed rapidly growing (a in 05/2011,
ow in a,b,d) lymph node metastases with infiltration of the right
ches of both pulmonary arteries (arrow in c). MRI of the thoracic (e)
Figure 6 Neuropathological results. In the astrocytoma WHO grade II (A II°, left row) density and pleomorphy of the tumor cells are low to
moderately pronounced. Tumor cells express GFAP, MAP2c, WT1 and mutated IDH1 (R132H). A subpopulation of ca. 1-2% shows a nuclear
accumulation of p53. The glioblastoma multiforme WHO grade IV (GB IV°) has a markedly increased density and pleomorphy, combined with an
increased mitotic and proliferative activity, necrotic areas and microvascular proliferations. Compared to the primary astrocytoma, GFAP
expression is present only in a subpopulation of tumor cells (ca. 65%) whereas nuclear accumulation of p53 occurs in more tumor cells (5-10%).
In the relapsed glioblastoma (rGB IV°) the percentage of tumor cells expressing GFAP (ca. 30%) and WT1 (ca. 10%) decreases. Both, the epidural
(emetGB IV°) as well as the pulmonal (pmetGB IV°) metastasis demonstrate expression of GFAP in 10-20% and of WT1 only in small groups and
single tumor cells (<10%). Bars = 50 μm, corresponding to a magnification ×200.
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RT and chemotherapy.
Conclusions
The first reported case of extraneural GB metastases was
in 1928 [4]. In 2008 Piccirilli et al. [2] have collected
about 128 cases of extraneural metastases of GB. Metas-
tases in many different regions of the body in our patient
with a secondary GB, especially the combination of lung
and osseous lesions with intraspinal involvement makes
this new case in many aspects unique. Most of the pa-
tients with extraneural GB lesions had metastases in the
lung (n = 44), osseous metastases occured as well
(n = 29), but there was only one other patient reported
with an intraspinal extradural metastasis [2], whereas
GB metastases are well known to spread through the
cerebrospinal fluid (CSF), as drop metastases [5,6].Nearly all (96%) reported patients with extraneural
metastases underwent cranial GB surgery beforehand
(Huang et al., 1995) [7], therefore the haematogenous
spreading of GB cells intraoperatively seems to be most
likely (Terheggen und Muller, 1977) [8]. Only very
rarely, GB patients treated without any surgery devel-
oped extraneural metastases [9].
Another special feature in our patient was the fact that
the last tumor resection surgery was at the same time a
revision for a chronic wound healing disturbance.
By enhancing global immune responses patients with
wound infections after GB resection are discussed to
have a longer overall survival compared to patients with-
out wound infections, although there is still no clear
proof for this theory (De Bonis et al., 2011) [10]. The
combination of wound infection and tumor resection
brings up the hypothesis that the chronic wound
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longer survival as usual - with the increased possibility
for developing extraneural metastasis - and on the other
hand the wound revision procedure itself maybe enabled
the haematogenous pathway for metastatic spread. Alter-
natively, one might suspect that the chronic inflamma-
tion in our case had opened the blood–brain barrier and
enabled the highly unusual extraneural and extracranial
metastatic spread in our case.
The fact that the overall survival in patients with GB
increased in the last decade [3] brings up the thoughts if
there shouldn’t be a more intensive focus on an appro-
priate staging for “long-term survivors” with GB.
We can reaffirm with our case that especially young
glioblastoma patients have the potential to develop
extraneural metastasis. We conclude that especially in
the case of the so called “long-term survivors” with re-
peated surgeries the possibility of extraneural metastasis
should be anticipated and an appropriate staging should
be performed early when suspected.
Based on the experience with our special case and
according to the current literature, we recommend ap-
propriate routine staging consisting of holospinal MRI
and CT of thorax and abdomen beside the routine cra-
nial MRI for “long-term survivors” with GB in case of
clinical suspicion of extraneural metastasis.
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